The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the post-prandial state is altered by a common deletion polymorphism of the apo B signal peptide

Atherosclerosis

Volumn 127, Issue 1, 1996, Pages 35-42

  Byrne, C D ^a   Wareham, N J ^b   Mistry, P K ^a   Phillips, D I W ^c   Martensz, N D ^a   Halsall, D ^a   Talmud, P J ^d   Humphries, S E ^d   Hales, C N ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

apolipoprotein B; free fatty acid; genotype; triglyceride; triglyceride rich lipoprotein

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 17444452371     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05932-1     Document Type: Article

References (36)

1. [1] Zilversmit DB. Atherogenesis: a post prandial phenomenon. Circulation 1979;60:473-485.
2. [2] Stender S, Zilversmit DB. Comparison of cholesteryl ester transfer from chylomicrons and other plasma lipoproteins to aorta intima-media of cholesterol-fed rabbits. Arteriosclerosis 1982;2:493-499.
3. [3] Simmons LA, Sweyer T, Simons J, et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case control study. Atherosclerosis 1987;65:181-189.
4. [4] Simpson HS, Williamson CM, Olivecrona T, et al. Post prandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 1990;85:193-202.
5. [5] Groot PHE, van Stiphout WA, Krauss XH, et al. Post prandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-662.
6. [6] Patsch JR, Miesenbsck G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease: studies in the post prandial state. Arterioscler Thromb 1992;12:1336-1345.
7. [7] Karpe F, Bard JM, Steiner G, Carlson LA, Fruchart JC, Hamsten A. HDLs and alimentary lipemia: studies in men with previous myocardial infarction at a young age. Arterioscler Thromb 1993;13:11-22.
8. [8] Byrne CD, Wareham NJ, Brown DC, et al. Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 1994;37:889-896.
9. [9] Byrne CD, Wareham NJ, Day NE, McLeish R, Williams DRR, Hales CN. Decreased non esterified fatty acid suppression and features of the insulin resistance syndrome in a sub-group of individuals with normal glucose tolerance. Diabetologia 1995;38:1358-1366.
10. [10] Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein gene is constitutively expressed in Hep G2 cells: regulation of secretion by oleic acid, albumin and insulin, and measurement of mRNA half life. J Lipid Res 1989;30:1065-1077.
11. [11] Byrne CD, Brindle NPJ, Wang TWM, Hales CN. Interaction of non esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J 1991;280:99-104.
12. [12] Byrne CD, Wang TWM, Hales CN. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem J 1992;288:101-107.
13. [13] Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoprotein B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 1993;90:2069-2073.
14. [14] Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36:62-67.
15. [15] Patsch JR. Post prandial lipaemia. In: Shepherd J, (ed). Bailliere's Clinical Endocrinology and Metabolism. Bailliere Tindall, 1987;1:551-580.
16. [16] Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
17. [17] Shimizu S. Enzymatic determination of serum-free fatty acids: a colorimetric method. Anal Biochem 1980;107:193-198.
18. [18] Kunkel LM, Smith KD, Boyer SH, et al. Analysis of human Y-chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977;74:1245-1249.
19. [19] Xu C-F, Talmud P, Schuster H, Houlston R, Miller G, Humphries SE. Association between genetic variation at the Apo AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clinical Genetics 1994;46:385-397.
20. [20] Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
21. [21] Myant NB, Gallagher JJ, Knight BL, et al. Clinical signs of familial hypercholesterolaemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function. Arterioscler Thromb 1991;11:691-703.
22. [22] Peacock SE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992;97:171-185.
23. [23] Sturley SL, Talmud PJ, Brasseur R, Culbertson MR, Humphries SE, Attie AD. Human apolipoprotein B signal sequence variants confer a secretion defective phenotype when expressed in yeast. J Biol Chem 1994;269:21670-21675.
24. [24] Boerwinkle E, Chan L. A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein (apo B) gene directly typed by the polymerase chain reaction. Nucleic Acids Res 1989;17:4003.
25. [25] Xu C-F, Tikkanen MJ, Huttunen JK, et al. Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 1990;31:1255-1261.
26. [26] Hixson JE, McMahan A, McGill HC Jr, Strong JP, the PDAY Research Group. Apolipoprotein B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Arterioscler Thromb 1992;12:1023-1029.
27. [27] Peacock R, Dunning A, Hamsten A, Torvall P, Humphries SE, Talmud P. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 1992;92:151-164.
28. [28] Myant NB, Gallagher J, Barbir M, Thompson GR, Wile D, Humphries SE. Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease. Atherosclerosis 1989;77:193-201.
29. [29] Renges H-H, Wile DB, McKeigue P, Marmot MG, Humphries SE. Apo B gene polymorphisms are associated with lipid levels in individuals of South Asian descent. Atherosclerosis 1991;92:267-275.
30. [30] Visvikis S, Cambou JP, Arveiler D, et al. Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. 'The ECTIM Study'. Hum Genet 1993;90:561-565.
31. [31] Peacock R, Karpe F, Talmud PJ, Hamsten A, Humphries SE. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study. Atherosclerosis 1995;116:135-145.
32. [32] Davis RA, Thrift RN, Wu CC, Howell KE. Apolipoprotein B is both intergrated into and translocated across the endoplasmic reticulum membrane. J Biol Chem 1990;265:10005-10011.
33. [33] Klausner RD, Sitia R. Protein degradation in the endoplasmic reticulum. Cell 1990;62:611-614.
34. [34] Dixon JL, Furakawa S, Ginsberg HN. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem 1991;266:5080-5086.
35. [35] Coppack SW, Evans RD, Fisher RM, et al. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 1992;41:264-272.
36. [36] Karpe F, Olivecrona T, Walldius G, Hamsten A. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res 1992;33:975-984.